Responsibility

R & D Strategy and Organization

Through the inquisitive spirit of our researchers, alongside our desire to contribute to the betterment of humanity, we’re working to create a competitive pipeline and quickly and consistently deliver innovative products. This supports our vision of becoming a Global Pharma Innovator with Competitive Advantage in Oncology.

Our Future Interests

To fulfill our mission of contributing to enriching lives globally, with quality & affordable pharmaceuticals, we continue to seek partners that match our values, work ethics and commitment to patients. Our focus areas for various segments are:

Cardiovascular (ALICE CARDIO DIVISION)

Metabolic Disorders

Oncology (ALICE CARES DIVISION)

 

Research and development stage priority areas

By implementing research and development initiatives that precisely address unmet medical needs our Group is contributing to improving the rate of satisfaction towards medical care in the future. Defining oncology as a primary focus area, we also aim to create advanced new drugs that revolutionize the SOC by advancing research and development targeting pain management, central nervous system disease, heart and kidney disease, and rare diseases as new horizon areas.